Division of Research and Economic Development

Expanding the University's research enterprise.

Biosafety Committee

The University of Rhode Island Institutional Biosafety Committee (IBC) reviews and approves Biological Research protocols.  Biological Research is defined as any laboratory research activity involving:

• Recombinant DNA (rDNA),

• Biological agents (i.e., viable infectious microorganisms (including prions) regardless of their pathogenicity to humans)

• Human or nonhuman primate materials

• Biological toxins subject to the National Select Agents Registry Program managed by the U.S. Departments of Health and Human Services (HHS) and Agriculture (USDA). The current list of toxins is identified at: http://www.selectagents.gov/index.html

Prior to commencing Biological Research, investigators must submit a protocol for review by the IBC. The IBC is established to ensure that Biological Research is conducted safely and that compliance is maintained with the following guidelines and regulations:

NIH Guideline for Research Involving Recombinant DNA Molecules (NIH Guidelines)

Occupational Safety and Health Administration–OSHA Bloodborne Pathogen Standard 1910.1030

CDC-USDA Select Agent Regulations


IBC Committee Information and Meeting Schedule

The IBC works in conjunction with the URI Institutional Animal Care and Use Committee (IACUC), the URI Institutional Review Board, and URI Environmental Health and Safety.

Think Big We Do

Copyright © 2017 University of Rhode Island.